Concepedia

Frank Jaehrling

FJ

Statistics

Publications

2

Citations

154

H-Index

2

Active since

2013

Affiliations

Merck (Germany)(Current)

Frank Jaehrling is an author at Merck (Germany) specializing in tumor biology, lung cancer, and cancer biology.

ORCID

Top concepts

Publications per year

2013–2020

2

Publications

2

EMD 1214063 and EMD 1204831 Constitute a New Class of Potent and Highly Selective c-Met Inhibitors

Friedhelm Bladt, Bettina Faden, Manja Friese‐Hamim et al. · Clinical Cancer Research · 2013 · 138 citations · Full text

SHP2 Inhibition Influences Therapeutic Response to Tepotinib in Tumors with MET Alterations

Linda Pudelko, Frank Jaehrling, Christof Reusch et al. · iScience · 2020 · 16 citations · Full text

, , +14

1–2 of 2